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Summary. — Adding to official development assistance (ODA), private foundations 
have emerged as important donors to the global health agenda. Amid this increasing 
funder diversity and growing global health budgets, responsiveness to recipients’ needs is 
a central concern. Merging datasets on ODA flows in 2005-2007, over 2,800 foundation 
grants, disease burden, and perceived priorities in 27 low- and middle-income countries, 
this study offers the first comprehensive national-level analysis of global health aid 
responsiveness. The analysis shows that national patterns of disease burden explain 
neither public nor private aid flows during this period. While ODA committed during 
these years was weakly yet significantly correlated with health priorities, private grants’ 
responsiveness was even weaker and did not achieve ODA significance levels either. 
 
Key words — global health, HIV-AIDS, official development assistance, private donors, 





* The authors especially thank Rachel Sullivan Robinson as well as Jo Beall, Robert 
Bench, Tom Bossert, Bill Brandon, Cassandra Maria Gallese, Miriam Laugesen, William 
J. Long, Peter Muennig, Thomas R. Oliver, Jeffrey O’Malley, Michael Reich and Jeremy 
Shiffman for helpful feedback and advice on several versions of the manuscript. Tim 
Kustusch and Ben Williams provided outstanding research and editorial support. Detailed 
comments by the editors and three anonymous reviewers proved pivotal in strengthening 
analysis and argument. All errors and omissions are entirely the authors’ responsibility. 
 1
Does Global Health Funding Respond to Recipients’ Needs?  
Comparing Public and Private Donors’ Allocations in 2005-2007 
 
Adding to official development assistance (ODA), private foundations have emerged as 
important donors to the global health agenda. Amid this increasing funder diversity and 
growing global health budgets, responsiveness to recipients’ needs is a central concern. 
Merging datasets on ODA flows in 2005-2007, over 2,800 foundation grants, disease 
burden, and perceived priorities in 27 low- and middle-income countries, this study offers 
the first comprehensive national-level analysis of global health aid responsiveness. Our 
analysis shows that national patterns of disease burden explain neither public nor private 
aid flows during this period. While ODA committed during these years was weakly yet 
significantly correlated with health priorities, private grants’ responsiveness was even 
weaker and did not achieve ODA significance levels either. 
 
Key words — global health, HIV-AIDS, official development assistance, private donors, 




Over the past five decades, bilateral as well as multilateral donors’ approaches to and 
rationales for funding health related development challenges have varied significantly. 
Aid policy during the 1960s focused on macroeconomic growth and public sector capital 
investment projects, while the 1970s saw a move toward human development initiatives. 
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Structural adjustment of the 1980s refocused the aid community’s attention on 
economics, this time with an emphasis on privatization and deregulation, only to be 
replaced in the new millennium by a return to human development with public-private 
partnerships taking center stage (Périn & Attaran, 2003). During the 1990s, globalization 
and the framing of health as a global public good with the potential to impact the national 
security and economic and political interests of both developed and developing countries 
(MacKellar, 2005; Archibugi & Bizzarri, 2005; Barrett, 2004) increasingly turned health 
policy making into a supranational, rather than domestic, process (McMichael & 
Beaglehole, 2000).  
 
At the turn of the millennium, awareness that the WHO’s ambitious proclamation of 
‘Health for All by 2000’ would not be achieved, coupled with disillusionment of the 
effectiveness of aid to low- and middle-income countries, prompted a renewed 
prioritization of health. Official development assistance (ODA) for health given by 
member countries of the Organization for Economic Cooperation and Development 
(OECD) has since doubled in real terms from 2000 to 2005 (Kates & Lief, 2007). US 
Government funding for HIV/AIDS programs in 2007 alone was around $2.3 billion, 
about eight times more than in 2000 (Ravishankar et al., 2009). In addition, major 
multilateral and bilateral funding mechanisms such as the US President’s Emergency 
Plan for HIV/AIDS (PEPFAR) and The Global Fund for AIDS, Tuberculosis, and 
Malaria (GFATM) were established in 2003 and 2005, respectively, to respond to 
growing political recognition of health needs of low- and middle-income countries.  At 
the same time, sources of aid diversified further through increased involvement of non-
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state donors: “From the [Bill and Melinda] Gates Foundation [BMGF] to the Clinton 
Global Initiative to the Millennium Project to the Make Poverty History Campaign to the 
Global Fund to Fight AIDS, Tuberculosis, and Malaria, there is now a flurry of global 
activities that tackle ‘banner’ diseases” (Pearlman & Roy, 2009: 18). Ravishankar et al. 
(2009: 2122) also observe that “[t]he role of NGOs in terms of spending funds from the 
public and private sectors has expanded tremendously, as has direct bilateral assistance to 
governments in low-income and middle-income countries. The shift is not only towards a 
smaller relative role for the UN system and the World Bank, but also for the changed 
status of these organizations.” Also during this decade, high level policy initiatives such 
as the Paris Declaration and the Disease Control Priorities Project have called for aid 
alignment with national priorities and disease burdens to meet a common goal of 
achieving important and sustainable gains in the health of people living in low- and 
middle- income countries (Shiffman, 2006; OECD, 2005; Jamison et. al., 2006). Based 
on “disability-adjusted life-year” (DALY) calculations designed to measure morbidity 
and mortality, the Global Burden of Disease Estimates from 2002 was the first global 
attempt to inform related policy-making (Murray & Lopez, 1996; Pearson & Rawlings, 
2005). Although the DALY methodology is not without critics (Arnesen & Nord, 1999), 
its applicability for defining and comparing disease burden across diseases and countries 
is apparent, and some authors have argued that the prioritization of maternal, newborn, 
and child health (Powell-Jackson et al., 2006) and HIV/AIDS (Shiffman, 2006) provide 
evidence that in some areas, needs do indeed trigger international financial flows. 
However, existing data on health expenditures equally suggests persistent imbalances and 
inconsistencies both globally and at the national level. Benatar et al. (2009: 349) find that 
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“[a]lmost 90% of world expenditure on health is spent on people bearing less than 10% 
of the global burden of disease, and 90% of expenditure on medical research is spent on 
diseases that account for a mere 10 percent of the global burden of disease.” Among the 
first publications to focus on allocations to developing country recipients specifically, 
MacKellar’s (2005) research identified wide gaps between health needs in developing 
countries and international funding priorities. Shiffman’s (2006) work provided further 
evidence that development assistance for communicable diseases and measures of disease 
burden are largely unaligned, and Wecker has argued that attention to diarrheal diseases, 
a major killer of infants, had waned dramatically since the 1980s partly as a result of 
changing donor priorities, which has allowed them to creep back (quoted in: Mason, 
2009).  At the same time, HIV/AIDS receives a seemingly disproportionate share of 
funding (Shiffman, 2006). This is illustrated by AIDS-related mortality figures in Nigeria 
and Ethiopia—Africa’s two most populous nations—in 2007 (237,000) which were “less 
than half the 540,000 children under 5 [in the same countries] who died of pneumonia 
and diarrhea” (Dugger, 2009). Yet in the same year, the US government’s budget for 
HIV-AIDS related interventions in Nigeria and Ethiopia “was more than the $646 million 
it is spending on maternal and child health in all the world’s countries combined” (ibid.). 
An additional complication arises when considering that a recent World Bank report 
alerts that seven out of ten Bank-financed HIV/AID projects fail to reach their objectives 
while nine out of ten projects targeting diseases such as malaria, tuberculosis, and leprosy 
performed satisfactorily or better (IEG, 2009).  
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Clearly then, donor allocations cannot be informed primarily by concerns about existing 
needs and the desire to improve health status in recipient countries in the most effective 
manner. Ravishankar et al. (2009: 2121) hypothesize “that country allocation of DAH 
[development assistance for health] is driven by many considerations, including income, 
burden of disease, political stability, and historical and political relations between 
specific donors and recipient countries,” thus echoing some of the arguments made by 
Shiffman (2006). Yet this does not imply that these factors have equal weight. Indeed, 
Périn and Attaran (2003) were among the first to argue that aid allocation for health is 
predominantly a political process determined by donor ideologies. Crane and Dusenberry 
(2004) emulated this point and emphasized religious underpinnings in the context of 
family planning and HIV prevention. More recently, Pearlman and Roy (2009: xiv) have 
reiterated this argument: “The practice of international health is political rather than 
technical, political rather than bureaucratic, political rather than academic. [...] The 
choice between interventions is presented as a question of efficacy that can be measured 
and scientifically evaluated. But the world is not that simple. Choices are often based on 
ideology, values, and national and organizational interests.” An important process in this 
context is the manipulation of recipient agendas by donors (Walt et al., 1999) that may 
result from one party controlling significant resources while the other party is in serious 
need (Sewell, 1992). Reflecting these concerns and based on their finding that “the focus 
on [...] quick results [by donors] discourages investment in health systems,” Sridhar and 
Rajaie (2008) hypothesize that either different governance structures of the World Bank, 
national governments, the BMGF and the Global Fund or ostensible comparative 
advantages between these agencies could explain differences in priority-setting processes.  
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That decision making structures matter is considered by other authors as well. Within 
private foundations, “the focus has been on amounts of money raised for high-visibility 
health problems. A large share of the new donor funding is being provided through 
channels earmarked for specific diseases or interventions” (Eichler et al., 2009: 42). The 
BMGF specifically has been characterized as “emphasiz[ing] breakthrough technologies 
and cost-effective interventions instead of investing in health-system strengthening and in 
addressing the underlying causes of disease” (Pearlman & Roy, 2009: 174). Another 
foundation has been singled out as pursuing a specific accomplishment in the health field 
to celebrate an important anniversary: “Rotary International had been looking for a global 
target to be achieved by the centennial of its foundation in 2005” (De Quadros, 2009: 62). 
Measurability plays an important role in this content because it facilitates resource 
mobilization as well as the production of easily attributable success stories (Esser, 2009), 
which causes Eichler et al. (2009: 4) to argue rather bluntly that “[y]ou get what you pay 
for. And it is easier to pay for what you can easily measure.” Finally, where shifts in 
donor priorities can neither be traced compellingly to shifts in recipient needs nor to 
provider interests, Shiffman (2006) argues that processes of socialization occurring 
within the global policy environment could provide an alternative explanation for these 
shifts.” Taking a social constructivist perspective and fielding the example of emerging 
health alliances during the past ten years, he posits that the decisions of one actor 




Although at least in part still hypothetical, this literature has nonetheless contributed in 
important ways to a deeper understanding of aid allocation. Yet the question remains to 
what extent both epidemiological profiles and subjective perceptions in recipient 
countries matter to different types of funders, if at all. Previous research into this aspect 
either did not break data down to the country level (Sridhar & Rajaie, 2008) or suffered 
from methodological problems. The authors of a recent BMGF-funded study that looks at 
both public and private sources, Ravishankar et al. (2009: 2113) argue that “[t]otal DAH 
received by low-income and middle-income countries was positively correlated with 
burden of disease.” They also find that “[t]he correlation between health aid and disease 
burden has risen from 0.6% to 0.8% between 1997 and 2007” (2121). However, the 
absence of per capita calculations in their approach constitutes a major limitation; 
asserting a direct correlation between DAH and DALYs without adjusting for population 
size is problematic since more populous countries are likely going to have larger disease 
burdens as well. What follows is that the statistical analysis offered by Ravishankar et al. 
is prone to type-I errors, i.e., detecting correlations where, in reality, there are none. 
Covering the period from 2005 until 2007, our research design merges datasets on ODA 
and private funding to nine major areas of health in 27 developing countries with disease 
burden indicators and data on recipients’ priority areas. While methods to measure 
country-specific disease burdens are widely used, public perceptions of health related 
challenges in local contexts are a relatively new area of measurement. The Kaiser/Pew 
Global Health Survey A Global Look at Public Perceptions of Health Problems, 
Priorities, and Donors (Kaiser Family Foundation, 2007) is the first attempt that allows 
for a comparative analysis of felt needs with indicators driven by epidemiological rather 
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than opinion data. On this basis, our study develops the first country-specific analysis of 
public and private donors regarding their responsiveness to two different 
conceptualizations of recipient needs, and thus offers a fresh look at the responsiveness of 




The Kaiser/Pew Global Health Survey (Kaiser Family Foundation, 2007) served as the 
benchmark for country selection as it covered 27 developing countries for which all other 
data sources also provided detailed information. The Survey is based on face-to-face 
interviews of sample sizes between 500 and 3142 people with national representation 
except Bolivia, Brazil, China, India, Pakistan, South Africa, and Venezuela in which 
largely urban populations were sampled.  Participants were surveyed between April and 
May 2007 and the responses were ranked on a scale from 1 to 9 (1 being highest priority) 
for current global health priorities comprising Access to Care, Build/Improve Facilities, 
Chronic Disease, Clean Water, HIV/AIDS, Hunger/Malnutrition, Immunizations, 
Prenatal Care, and TB/Malaria/Other Infectious Diseases according to the percentage of 
people who cited each issue as “one of the most important” public health priorities for 
government to address.  The limitation of the ranking is that it is relative. For instance, 
gaining top priority for an issue in a country can range between obtaining near universal 
support at 95% (HIV/AIDS in Ethiopia) to much more dispersed results like 43% 
(Immunizations in China) of the response.  Nonetheless, this survey represents the first 
comprehensive look at the perceived global health priorities of people living in low and 
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middle income countries. In addition to our country-level analysis, we also form regional 
clusters as another analytical dimension. Regions are broken down into sub-Saharan 
Africa, Latin America, Asia, and the Middle East. Sub-Saharan Africa includes Ethiopia, 
Ghana, Kenya, Mali, Nigeria, Senegal, South Africa, Tanzania, and Uganda. Latin 
America includes Argentina, Bolivia, Brazil, Chile, Mexico, Peru and Venezuela. Asia 
includes Bangladesh, China, India, Indonesia, Malaysia, and Pakistan. The Middle East 
includes Egypt, Jordan, Lebanon, Morocco, and Turkey [2].  
 
Official development assistance committed between 2005 and 2007 was obtained from 
the OECD online Creditor Reporting System (CRS) of total ODA including bilateral and 
multilateral sources (SourceOECD, 2009). Commitments only were chosen to represent 
the priorities as postulated by donor agencies, unadulterated by extraneous factors such as 
budgeting shortfalls that may impact disbursements but may have little to do with the 
intended level of priority (cf. Sridhar & Rajaie, 2008). US private foundations’ grant 
authorizations made during the period from 2005 until 2007 were obtained from the 
Foundation Center website (Foundation Directory Online 2008a), which provides a 
detailed overview of large-scale non-governmental giving from US-based accounts. 
Based on a ranking of all US-based foundations and their cumulative funding of global 
health issues in the first of the three years studied (2005), the top five foundations in 
global health in terms of their individual grants were identified (Foundation Directory 
Online 2008b). These are the BMGF, the Ford Foundation, the David and Lucille 
Packard Foundation, the William and Flora Hewlett Foundation, and the Susan 
Thompson Buffett Foundation. Taken together, these five sources account for 95, 92, and 
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89 per cent of total funding by U.S. foundations between 2005 and 2007, respectively 
(see Table 1). Multi-year grants were included in the analysis in their entirety whereas 
grants with a regional focus—instead of a country—were excluded. Since ODA data are 
often also multiyear commitments, multi-year grants were taken as a lump grant and not 
imputed over the years of the grant in order to capture the signalling function of the 
commitment at a given point in time.   
 
[add table 1 about here] 
 
All grants (n=2,847) from these top five foundations (n=5) in terms of health 
commitments for countries included in the study (n=27) were searched for “health”, 
“hunger”, “nutrition”, then read individually and placed in most relevant Kaiser category. 
“Reproductive health” grants in the Foundation Center database (a separate keyword in 
the foundation center database) were categorized as “Prenatal Care” unless more 
appropriate in another category (for instance, HIV/AIDS).  Because of the difficulty of 
capturing solely Prenatal Care in both ODA and Private Foundation Data, Prenatal Care 
is characterized as a more general “Reproductive Health Care.” For this reason, in this 
analysis, Prenatal Care is likely to be overestimated in terms of funding and is better seen 
as a proxy variable. A similar challenge, hunger and malnutrition are, in practice, linked 
across several disease categories, for instance HIV/AIDS, yet such multiple attribution 
cannot be accounted for in this type of analysis (cf. Anabwani and Navario, 2005). ODA 
and private grant and loan commitments for 2005, 2006, and 2007 were grouped into 
categories consistent with the Kaiser/Pew Survey (see Figure 1). The purpose codes 
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Basic Health Care (12220) and Infectious Disease Control (12250) were searched 
individually for reference to immunization, vaccination and relegated accordingly.  
 
[add figure 1 about here] 
 
DALY data for the 27 countries were obtained through the Global Burden of Disease 
Estimates (WHOSIS; cf. WHO 2002) database. All categories in the WHOSIS database 
were included except Injuries. With the exception of ‘Access to Care’ and 
‘Build/Improve Facilities’ which had no direct attributable DALYs and were therefore 
excluded, estimated disease burden was attributed to each of the categories found in the 
Kaiser/Pew Survey. Clean Water comprised all DALYs attributable to diarrheal disease. 
Chronic disease included all DALYs attributed to non-communicable disease. 
Immunizations included all DALYs attributable to the childhood cluster diseases 
(poliomyelitis, measles, pertussis, tetanus, and diphtheria). HIV/AIDS included all 
DALYs attributable to HIV/AIDS and STDs. Prenatal care included perinatal conditions 
and maternal conditions. TB/Malaria/Other Infectious diseases included communicable 
diseases including tuberculosis, malaria, intestinal nematode infections, dengue, hepatitis, 
meningitis, trachoma, tropical cluster diseases (Chagas disease, lymphatic filariasis, etc.), 
Japanese encephalitis, leprosy, and respiratory infections. Hunger and Malnutrition 
comprised all nutritional deficits including Vitamin A, iodine, iron and protein [3]. We 
collapsed the aid variable into ordinal categories and used Spearman’s rho to test the 
relationship.  It is worth noting that because of the reverse demarcation of priorities (1—
not 9—being the highest), a negative algebraic sign denotes a positive correlation. 
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Pearson’s r and Spearman’s rho were calculated using SPSS 16.0 to analyze correlations 
between official development assistance and private foundation giving to disease burden 
(r) and perceived priority (rho). Significance was determined at 95% and 99% confidence 
intervals (2-tailed).  Since the application of Spearman’s rho to denote correlation 
between one ordinal and one interval-ratio set of data may seem problematic, we also 
converted aid figures into ordinal variables by forming nine categories for ODA amounts 
and five for private grants and then recalculated the coefficient. This produced virtually 
identical results, rendering Spearman’s rho remarkably robust with only one ordinal 
variable. In addition, we calculated Pearson’s r. While producing lower values of the 




Alignment of donor aid commitments and private funding by the leading five US-based 
private foundations between 2005 and 2007, public priorities in 27 recipient countries, 
and country-level disease burden varied greatly across regions. Looking first at total 
international funding to countries included in the study, India and China received by far 
the highest total amounts of health aid from both types of funders. Ethiopia was the third 
most-funded recipient country and first among the nine African countries sampled. 
Bangladesh, Kenya, Nigeria, Tanzania, South Africa and Indonesia follow on ranks four 
to ten. With an increase from over $2.6bn to just shy of $4.7bn, the nine countries in sub-
Saharan Africa also represent the greatest absolute expansion in ODA health funding 
during the three-year period covered. The greatest relative increase can be registered for 
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the seven countries located in Latin America; however, funding for health purposes also 
fluctuated most within this region, with Mexico experiencing the sharpest decline in 
health ODA received among all 27 countries included in the study, from over $265m in 
2005 down to $13m in 2007. The only regional group to undergo a decline in health-
related ODA between 2005 and 2007, the five Middle Eastern countries saw their share 
reduced from just under $1bn in 2005 to $620m in 2006 and still only $725m in 2007. 
 
For the five foundations whose grants were analyzed for this study, Nigeria was the most 
prominent target country, receiving almost $100m over a three-year period. India, Kenya, 
and Ghana follow on ranks two to four. However, private grants for health projects 
located in India nonetheless also registered the sharpest absolute decline, from over $44m 
in 2005 to under $17m in 2007. Conversely, Pakistan experienced the greatest relative 
expansion, seeing private health aid increase from $1.3m in 2005 to over $21m in 2007. 
In absolute terms, this ranking is led by private grants for aid projects in Nigeria where 
overall private funding jumped from $9.3m in 2005 to just under $60m one year later. 
Notably, whereas ODA for health purposes committed to the Asian region between 2005 
and 2007 was 40% higher than commitments to Africa, private foundation giving actually 
showed a reverse pattern, with African countries receiving over 60% more than private 
grants authorized for projects located in Asia. No grants from foundations covered in the 
analysis were given to Bolivia, Jordan, Lebanon, or Venezuela (see Table 2).  
 
[add table 2 about here] 
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Regarding the responsiveness of ODA and private funding to national disease burdens, 
our calculations rendered weak statistical correlations for both sources and all three years 
reported, none of which were estimated to be significant at the .95 confidence level.  
With respect to perceived priorities, we found stronger correlations between ODA and 
priorities as reported by the Kaiser/Pew Global Health Survey, which were also estimated 
to be highly significant. Lower indicators of association resulted for private foundation 
giving and national priorities, and only one of the coefficients—i.e., private grants 
awarded in 2005—was estimated to be significant at the .95 confidence level.  
 
[add table 3 about here] 
 
The absence of strong correlations between funding streams and disease burden also hints 
at a similarly weak correlation between priority ranks and disease burden. This was 
indeed the case. For instance, despite contributing 24 per cent and 12 per cent, 
respectively, to disease burdens in sub-Saharan Africa and Asia, tuberculosis, malaria and 
other infectious disease were ranked among the lowest priorities by respondents in the 15 
countries included from these two regions. At the other end of extremes, HIV/AIDS was 
ranked the most important health priority in Asia even though this category contributed to 
only 3 per cent of the total disease burden. Still, following Clean Water, HIV/AIDS was 
the next most highly funded health category in Asia overall and the most highly funded 
one by the five private foundations included in the study (see Table 4). 
 
[add table 4 about here] 
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In order to examine to what extent funding by both types of sources was aligned with 
disease burden at the country-level, we also created an index of per capita disease burden 
for each country by dividing the total disease burden for each country by the national 
population as specified in the Global Burden of Disease Estimates. The total amount of 
aid given to that country was then divided by this index. We did not find strong evidence 
of responsiveness at this level either. Among the sub-Saharan countries included in the 
study, Mali had the highest DALYs-per-capita index (0.68) but received the lowest 
relative amounts of aid within the sub-Saharan sample from each type of source. Only 
Venezuela—whose DALYs-per-capita index score was less than 25 per cent of Mali’s—
received less funding per capita and disease burden. The highest private flows, relative to 
disease burden, went to Kenya, which ranks seventh out of nine countries in terms of per 
capita disease burden. Kenya also came out second in the ODA ranking, topped only by 
Ethiopia, which in terms of per capita disease burden ranks fifth within the sub-Saharan 
sample. The situation was similar for the six Asian and five Middle Eastern countries 
sampled. China, with a DALYs-per-capita index score of 0.15, received eleven times the 
amount of grant and loan commitments compared to Pakistan, which bears twice the per 
capita disease burden. Egypt and Lebanon ranked at the top of their region’s per capita 
disease burden index but together received less funding than Turkey, ranked fourth out of 
five. Cross-regional comparisons complement this picture further; although Bolivia had a 
slightly higher per capita burden than Bangladesh, the latter country received more than 
five times the financial aid on a per capita basis than the Andean state (see Table 5). 
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The results described in the previous section allow us to revisit the alternative drivers of 
health aid allocation already discussed above, with a view to assessing their relative 
explanatory power. To begin with, Ravishankar’s et al. (2009, op.cit.) hypothesis “that 
country allocation of DAH is driven by many considerations, including income, burden 
of disease, political stability, and historical and political relations between specific donors 
and recipient countries” finds some support. While our study does not test the relevance 
of donor incomes to this context, we do observe that private foundations seem to prefer 
politically stable recipient countries (see table 2). At the same time, countries that have 
been relatively stable in the recent past—at least when compared to some countries 
included in the sub-Saharan sample—but during the period of 2005 to 2007 were led by 
interventionist and redistributive governments were either shunned completely, as in the 
case of private foundations, or received markedly less ODA (both in absolute terms and 
when compared on the basis of per capita disease burden). This supports arguments about 
the highly politicized nature of health aid allocation as fielded by both Périn and Attaran 
(2003) and Pearlman and Roy (2009). The finding also resonates with the literature on 
aid distribution more generally (Barnebeck Anderson et al., 2006).  
 
Conversely, we find very little evidence for disease burdens as allocative drivers. Rather, 
the focus in 2005-07 seems to indeed have “been on […] high-visibility health problems” 
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(Eichler et al., op.cit.). Despite being more of a logical extension than an actual finding 
from our analysis, it also seems that measurability of outputs (Esser, 2009)—a necessary 
yet insufficient condition for the subsequent attribution of successful intervention to 
specific agencies or foundations—may well constitute another important component of 
the equation to explain prioritization among public and private donors.  
 
The above pattern is substantiated further by the dearth of funding for the prevention and 
treatment of chronic diseases (see table 4) even though these diseases comprised the 
highest contributor to overall disease burden in all regions except sub-Saharan Africa, 
where chronic disease was a close second at 19% to HIV/AIDS (which accounted for 
20%). This finding confirms the concern that “[a]bout half of the global burden of disease 
is attributable to chronic conditions and exceeds the burden of communicable diseases in 
all countries except the poorest.” (Eichler et al., 2009: 32) However, whereas the OECD 
dataset does not even include codes applicable to this category (explaining the absence of 
ODA commitments to this group of diseases), it should be noted that private foundations 
did in fact make small investments in this area. For 2005, the Foundation Center database 
recorded a total of $214,000 spent on such diseases in Kenya and South Africa. In 2006, 
private donors allocated $465,000 in this category to a Chinese project and $70,000 to a 
Pakistani scheme. An additional $120,000 was granted to China during the following 
year, together with $50,000 for a project in Nigeria and $10,000 in support of a Kenyan 




5. CONCLUDING REMARKS 
 
We would like to see this study being used as a starting point for follow-up investigations 
of two types of agencies, namely donors and ministries in recipient countries, in order to 
contribute to a better understanding of decision making dynamics within organizations 
pivotal for the improvement of health systems and outcomes in developing countries. For 
instance, while our study considers official aid commitments as well as private funding 
from the top five US-based private foundations, we do not account for in-country funding 
sources. Inclusion of such data strikes us as a promising extension of this research in that 
it would add to the existing literature assessing the degree of ‘crowding out’ of national 
funding by international aid (Lu et al., 2010; Sridhar, 2009; Waddington, 2004; cf. 
Michaud & Murray, 1994). To illustrate, large amounts of international aid targeted at a 
specific disease may drive up public prioritization as people become more aware of the 
issue. This argument has been particularly salient in the context of funding for HIV/AIDS 
and its critique (Shiffman, 2008). At the same time, the only way to test Sridhar and 
Rajaie’s (2008) hypothesis that either the governance structures of donor agencies or their 
internal perception of comparative advantages might explain differences in priority-
setting would be to actually engage with these organizations in depth and for a substantial 
amount of time. Moving beyond generalized statements or even conspiracy theories, this 
approach would focus on uncovering the actual political economies at different levels of 
policy making through embedded observation (cf. Esser, 2009; Sridhar and Rajaie, 2008). 
It then seems to us that such inquiries into formal as well as informal processes of 
prioritization require a research design which is quite different from the currently 
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dominant macro-level large-n studies of development assistance for health, and that the 




[1] Donor partnerships such as the GFATM as well as World Bank-led investment 
alliances command considerable amounts of money and can provide an important 
opportunity for donor coordination. At the same time, such alliances have raised concerns 
over ‘reverticalizing’ health systems and further complicating the administrative 
requirements of international health assistance (Buse & Harmer, 2007: 263). Investment 
alliances in particular are monitored with skepticism regarding their ownership structures 
and the role of private companies with little healthcare knowledge beyond their domestic 
markets (Lethbridge, 2005; Attaran et al., 2006). 
 
[2] Although Eastern and Central European countries were included in the Kaiser/Pew 
Survey, no official development assistance for health was reported for this region and it 
was therefore omitted from the analysis. 
 
[3] One might argue that international aid in absolute terms is a limited variable since 
some interventions may cost more than others but also lead to greater gains in DALYs. 
To this effect, a comparison of the cost-effectiveness of interventions would be necessary 
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Access to Care 208,281 0 208,281 40,791 0 40,791 18,859 500 19,359 268,430 - - 7 
Build/Improve Facilities 4,701 0 4,701 1,557 0 1,557 894 0 894 7,152 - - 3 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 15,042 41% 8 
Clean Water 87,004 0 87,004 339,055 0 339,055 286,773 0 286,773 712,832 2,298 6% 9 
HIV/AIDS 4,895 23 4,918 18,596 0 18,596 23,046 0 23,046 46,559 350 1% 1 
Hunger and Malnutrition 381,303 0 381,303 82,201 14,967 97,168 106,950 5,250 112,200 590,671 1,306 4% 5 
Immunizations 285 0 285 184 0 184 658 0 658 1,127 1,459 4% 4 
Prenatal Care 31,780 75 31,855 63,324 25,501 88,825 43,739 0 43,739 164,418 4,505 12% 2 
TB/Malaria/OID 0 0 0 35,950 0 35,950 20,321 0 20,321 56,271 5,924 16% 6 
China              
Access to Care 6,284 292 6,577 9,331 489 9,820 16,637 270 16,907 33,305 - - 5 
Build/Improve Facilities 22,103 0 22,103 39,393 0 39,393 28,563 0 28,563 90,059 - - 7 
Chronic Disease 0 0 0 0 465 465 0 120 120 585 
133,05
6 66% 8 
Clean Water 1,149,058 0 1,149,058 879,284 0 879,284 934,379 0 934,379 2,962,722 5,055 3% 2 
HIV/AIDS 37,112 3,787 40,900 135,679 552 136,231 143,118 21,406 164,524 341,654 1,425 1% 4 
Hunger and Malnutrition 486 0 486 0 0 0 3,911 0 3,911 4,396 2,553 1% 9 
Immunizations 843 0 843 376 0 376 4,516 0 4,516 5,735 1,039 1% 1 
Prenatal Care 3,456 671 4,127 4,355 1,041 5,395 3,789 607 4,396 13,919 13,585 7% 6 
TB/Malaria/OID 59,019 120 59,139 44,780 0 44,780 45,079 70 45,149 149,067 12,650 6% 3 
India              
Access to Care 41,134 24,746 65,880 219,299 15,937 235,236 288,709 1,710 290,419 591,534 - - 8 
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Build/Improve Facilities 22,455 145 22,601 102,305 0 102,305 1,205 0 1,205 126,110 - - 5 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 
124,09
9 41% 2 
Clean Water 544,397 0 544,397 732,737 0 732,737 912,871 0 912,871 2,190,005 15,254 5% 4 
HIV/AIDS 237,264 11,916 249,180 32,551 6,254 38,806 819,252 8,340 827,592 1,115,578 13,110 4% 1 
Hunger and Malnutrition 42,630 300 42,930 48,710 0 48,710 41,579 200 41,779 133,419 8,120 3% 6 
Immunizations 26,811 0 26,811 54,546 0 54,546 134,206 0 134,206 215,563 10,323 3% 7 
Prenatal Care 26,189 7,465 33,654 835,919 5,989 841,907 514,882 6,352 521,233 1,396,795 37,863 13% 3 
TB/Malaria/OID 116,512 0 116,512 155,840 0 155,840 69,508 0 69,508 341,860 42,643 14% 9 
Indonesia              
Access to Care 33,544 250 33,794 25,761 0 25,761 4,332 349 4,680 64,236 - - 2 
Build/Improve Facilities 36,015 0 36,015 63,961 0 63,961 16,841 0 16,841 116,817 -  3 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 25,959 56% 9 
Clean Water 187,557 0 187,557 290,641 0 290,641 65,388 0 65,388 543,586 1,264 3% 7 
HIV/AIDS 99,806 465 100,271 28,535 1,300 29,835 23,274 0 23,274 153,379 462 1% 5 
Hunger and Malnutrition 23,166 0 23,166 11,491 0 11,491 64,338 0 64,338 98,995 1,375 3% 1 
Immunizations 0 0 0 0 0 0 0 0 0 0 1,451 3% 6 
Prenatal Care 49,048 1,521 50,569 6,468 1,496 7,965 18,847 1,525 20,372 78,905 3,894 8% 4 
TB/Malaria/OID 65,464 0 65,464 45,276 0 45,276 25,993 207 26,199 136,940 5,325 11% 8 
Malaysia              
Access to Care 341 0 341 58 79 137 25 0 25 503 - - 5 
Build/Improve Facilities 0 0 0 0 0 0 0 0 0 0 - - 1 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 2,440 70% 4 
Clean Water 745,582 0 745,582 164 0 164 1,020 0 1,020 746,766 28 1% 3 
HIV/AIDS 156 0 156 144 0 144 310 0 310 609 112 3% 2 
Hunger and Malnutrition 0 0 0 0 0 0 0 0 0 0 106 3% 9 
Immunizations 0 0 0 0 0 0 0 0 0 0 16 0% 8 
Prenatal Care 0 670 670 0 772 772 130 811 941 2,383 121 3% 6 
TB/Malaria/OID 0 0 0 0 0 0 450 0 450 450 244 7% 7 
Pakistan              
Access to Care 26,458 0 26,458 180,652 0 180,652 16,796 574 17,371 224,481 - - 8 
Build/Improve Facilities 13,579 0 13,579 33,100 0 33,100 954 0 954 47,634 - - 7 
Chronic Disease 0 0 0 0 70 70 0 0 0 70 15,326 34% 1 
Clean Water 46,923 0 46,923 24,590 0 24,590 27,117 0 27,117 98,629 3,904 9% 4 
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HIV/AIDS 317 0 317 6,957 0 6,957 9,271 0 9,271 16,545 1,116 2% 3 
Hunger and Malnutrition 16,901 0 16,901 31,319 0 31,319 22,653 4,251 26,904 75,125 1,405 3% 2 
Immunizations 19,036 0 19,036 18,071 0 18,071 48,326 0 48,326 85,433 2,890 6% 6 
Prenatal Care 34,848 1,300 36,148 45,062 1,080 46,142 31,022 2,579 33,600 115,891 5,919 13% 5 
TB/Malaria/OID 15,507 0 15,507 15,536 0 15,536 32,552 14,129 46,681 77,724 6,866 15% 9 
Latin America              
Argentina              
Access to Care 19,534 0 19,534 301,959 0 301,959 1,791 0 1,791 323,284 - - 4 
Build/Improve Facilities 295 0 295 92 0 92 42,435 0 42,435 42,822 - - 2 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 4,774 76% 8 
Clean Water 108 0 108 40,376 0 40,376 354,560 0 354,560 395,044 49 1% 3 
HIV/AIDS 17,170 0 17,170 406 150 556 440 50 490 18,217 101 2% 7 
Hunger and Malnutrition 102 0 102 273 0 273 240 0 240 616 46 1% 1 
Immunizations 330 0 330 0 156 156 0 0 0 486 12 0% 5 
Prenatal Care 178 0 178 209 0 209 170 0 170 557 299 5% 6 
TB/Malaria/OID 0 0 0 0 0 0 0 0 0 0 175 3% 9 
Bolivia              
Access to Care 21,927 0 21,927 33,156 0 33,156 7,757 0 7,757 62,840 - - 7 
Build/Improve Facilities 18,338 0 18,338 7,716 0 7,716 5,727 0 5,727 31,781 - - 6 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 1,086 46% 8 
Clean Water 16,138 0 16,138 66,585 0 66,585 48,920 0 48,920 131,643 142 6% 3 
HIV/AIDS 1,063 0 1,063 3,595 0 3,595 10,475 0 10,475 15,133 16 1% 5 
Hunger and Malnutrition 19,628 0 19,628 42,154 0 42,154 27,687 0 27,687 89,469 78 3% 1 
Immunizations 0 0 0 0 0 0 0 0 0 0 17 1% 4 
Prenatal Care 2,616 0 2,616 909 0 909 7,520 0 7,520 11,046 326 14% 2 
TB/Malaria/OID 1,761 0 1,761 5,283 0 5,283 6,999 0 6,999 14,043 304 13% 9 
Brazil              
Access to Care 6,443 441 6,884 6,674 1,206 7,880 4,939 200 5,139 19,902 - - 2 
Build/Improve Facilities 915 25 940 667 0 667 290 25 315 1,922 - - 3 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 23,112 63% 4 
Clean Water 78,422 0 78,422 197,455 0 197,455 50,137 0 50,137 326,013 735 2% 8 
HIV/AIDS 3,799 200 3,999 2,847 125 2,972 5,666 2,391 8,056 15,027 612 2% 7 
Hunger and Malnutrition 303 0 303 119 0 119 111 0 111 533 399 1% 1 
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Immunizations 0 0 0 0 0 0 0 0 0 0 64 0% 5 
Prenatal Care 334 979 1,312 279 3,064 3,343 511 800 1,311 5,965 3,510 10% 6 
TB/Malaria/OID 1,860 0 1,860 15,021 0 15,021 2,753 0 2,753 19,635 1,910 5% 9 
Chile              
Access to Care 1,985 0 1,985 440 0 440 281 0 281 2,706 - - 2 
Build/Improve Facilities 165 0 165 18 0 18 40 0 40 222 - - 3 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 1,668 76% 4 
Clean Water 191 0 191 89 0 89 140,986 0 140,986 141,267 19 1% 6 
HIV/AIDS 24,592 0 24,592 28 0 28 71 0 71 24,690 51 2% 8 
Hunger and Malnutrition 57 0 57 0 0 0 0 0 0 57 10 0% 1 
Immunizations 0 0 0 0 0 0 0 0 0 0 4 0% 5 
Prenatal Care 158 0 158 87 14,517 14,603 147 425 572 15,334 78 4% 7 
TB/Malaria/OID 0 0 0 10 0 10 0 0 0 10 69 3% 9 
Mexico              
Access to Care 5,679 0 5,679 7,857 0 7,857 1,061 0 1,061 14,597 - - 2 
Build/Improve Facilities 18 0 18 138 0 138 25 0 25 181 -  6 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 10,301 67% 8 
Clean Water 257,255 0 257,255 54,487 0 54,487 7,561 0 7,561 319,303 254 2% 3 
HIV/AIDS 1,582 350 1,932 4,365 60 4,425 2,200 300 2,500 8,857 241 2% 7 
Hunger and Malnutrition 0 0 0 0 5,800 5,800 190 150 340 6,140 262 2% 1 
Immunizations 0 0 0 0 0 0 10 0 10 10 36 0% 5 
Prenatal Care 728 938 1,666 486 560 1,046 455 1,414 1,869 4,581 1,306 8% 4 
TB/Malaria/OID 4 0 4 4 0 4 1,500 0 1,500 1,508 661 4% 9 
Peru              
Access to Care 15,998 0 15,998 14,424 0 14,424 3,892 0 3,892 34,314 - - 5 
Build/Improve Facilities 1,238 0 1,238 1,674 0 1,674 5,894 0 5,894 8,805 - - 3 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 2,912 57% 9 
Clean Water 12,456 0 12,456 30,637 0 30,637 208,772 0 208,772 251,865 171 3% 2 
HIV/AIDS 1,746 0 1,746 18,146 0 18,146 26,842 0 26,842 46,734 167 3% 4 
Hunger and Malnutrition 7,701 0 7,701 33,608 0 33,608 7,453 0 7,453 48,762 139 3% 1 
Immunizations 2,100 0 2,100 0 0 0 4 0 4 2,104 23 0% 7 
Prenatal Care 1,343 0 1,343 1,917 0 1,917 7,311 310 7,621 10,882 461 9% 6 
TB/Malaria/OID 730 0 730 19,591 599 20,191 1,379 1,695 3,074 23,995 536 10% 8 
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Venezuela              
Access to Care 327 0 327 271 0 271 1,205 0 1,205 1,802 - - 6 
Build/Improve Facilities 122 0 122 30 0 30 251 0 251 403 - - 3 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 2,473 60% 5 
Clean Water 14,669 0 14,669 256 0 256 89 0 89 15,015 71 2% 8 
HIV/AIDS 129 0 129 210 0 210 370 0 370 709 150 4% 2 
Hunger and Malnutrition 40 0 40 10 0 10 120 0 120 170 47 1% 1 
Immunizations 0 0 0 0 0 0 0 0 0 0 17 0% 7 
Prenatal Care 1,054 0 1,054 651 0 651 303 0 303 2,008 289 7% 4 
TB/Malaria/OID 0 0 0 0 0 0 150 0 150 150 127 3% 9 
Middle East              
Egypt              
Access to Care 6,740 150 6,890 7,805 0 7,805 32,615 0 32,615 47,310 - - 4 
Build/Improve Facilities 168 0 168 235 0 235 1,689 0 1,689 2,091 - - 1 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 9,153 67% 6 
Clean Water 119,315 0 119,315 54,412 168 54,580 127,253 0 127,253 301,148 464 3% 3 
HIV/AIDS 589 332 921 839 300 1,139 3,059 320 3,379 5,440 106 1% 5 
Hunger and Malnutrition 452 0 452 1,371 0 1,371 1,371 0 1,371 3,194 322 2% 2 
Immunizations 588 0 588 1,451 0 1,451 227 0 227 2,266 88 1% 9 
Prenatal Care 2,393 605 2,998 1,548 1,050 2,598 13,998 26 14,024 19,620 1,131 8% 7 
TB/Malaria/OID 3,330 0 3,330 1,417 0 1,417 20,208 0 20,208 24,955 1,197 9% 8 
Jordan              
Access to Care 497 0 497 815 0 815 1,560 0 1,560 2,872 - - 6 
Build/Improve Facilities 26 0 26 4,493 0 4,493 493 0 493 5,012 - - 2 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 488 58% 3 
Clean Water 138,360 0 138,360 101,146 0 101,146 58,102 0 58,102 297,608 26 3% 4 
HIV/AIDS 711 0 711 10 0 10 3,756 0 3,756 4,477 6 1% 5 
Hunger and Malnutrition 10,000 0 10,000 0 0 0 9 0 9 10,009 32 4% 1 
Immunizations 0 0 0 0 0 0 0 0 0 0 3 0% 7 
Prenatal Care 146 0 146 343 0 343 7,495 0 7,495 7,984 41 5% 8 
TB/Malaria/OID 0 0 0 1,073 0 1,073 0 0 0 1,073 51 6% 9 
Lebanon              
Access to Care 4,168 0 4,168 11,114 0 11,114 7,582 0 7,582 22,864 - - 1 
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Build/Improve Facilities 589 0 589 258 0 258 451 0 451 1,297 - - 2 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 439 67% 6 
Clean Water 91,741 0 91,741 17,377 0 17,377 26,626 0 26,626 135,744 11 2% 5 
HIV/AIDS 75 0 75 1 0 1 120 0 120 196 6 1% 9 
Hunger and Malnutrition 2,470 0 2,470 12,847 0 12,847 190 0 190 15,507 11 2% 3 
Immunizations 0 0 0 0 0 0 180 0 180 180 1 0% 4 
Prenatal Care 247 0 247 272 0 272 1,251 0 1,251 1,771 23 4% 7 
TB/Malaria/OID 0 0 0 0 0 0 0 0 0 0 28 4% 8 
Morocco              
Access to Care 4,283 0 4,283 2,173 0 2,173 10,229 0 10,229 16,686 - - 5 
Build/Improve Facilities 6,378 0 6,378 9,785 0 9,785 5,999 0 5,999 22,162 - - 9 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 2,939 57% 3 
Clean Water 199,829 0 199,829 336,788 0 336,788 235,385 0 235,385 772,002 232 4% 6 
HIV/AIDS 5,500 0 5,500 420 0 420 12,093 170 12,263 18,183 49 1% 2 
Hunger and Malnutrition 7 0 7 386 0 386 80 0 80 473 195 4% 1 
Immunizations 0 0 0 0 0 0 1,490 0 1,490 1,490 70 1% 7 
Prenatal Care 2,682 0 2,682 3,804 0 3,804 5,451 0 5,451 11,937 666 13% 4 
TB/Malaria/OID 0 0 0 10 0 10 2,220 0 2,220 2,230 380 7% 8 
Turkey              
Access to Care 444 0 444 549 0 549 326 0 326 1,319 - - 2 
Build/Improve Facilities 50 0 50 79 0 79 2,464 0 2,464 2,593 -  3 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 7,492 65% 4 
Clean Water 321,355 0 321,355 208 0 208 140,529 0 140,529 462,092 236 2% 6 
HIV/AIDS 3,984 0 3,984 84 0 84 220 0 220 4,288 46 0% 7 
Hunger and Malnutrition 0 0 0 0 0 0 70 0 70 70 276 2% 1 
Immunizations 0 0 0 125 0 125 105 0 105 230 221 2% 8 
Prenatal Care 519 0 519 316 575 891 287 600 887 2,297 949 8% 5 
TB/Malaria/OID 6,844 0 6,844 45,881 0 45,881 0 0 0 52,725 904 8% 9 
Sub-Saharan Africa              
Ethiopia              
Access to Care 39,327 45 39,372 66,004 1,246 67,250 57,486 15,049 72,535 179,157 - - 8 
Build/Improve Facilities 1,454 0 1,454 3,958 0 3,958 4,238 0 4,238 9,649 - - 7 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 7,339 20% 6 
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Clean Water 19,193 0 19,193 176,680 0 176,680 186,707 0 186,707 382,580 2,100 6% 4 
HIV/AIDS 115,689 0 115,689 177,772 15,214 192,986 599,695 240 599,935 908,610 4,528 12% 1 
Hunger and Malnutrition 211,139 0 211,139 100,569 0 100,569 81,788 0 81,788 393,496 1,388 4% 2 
Immunizations 7,030 0 7,030 3,910 0 3,910 28,010 0 28,010 38,950 2,198 6% 9 
Prenatal Care 4,024 3,261 7,285 39,180 4,600 43,780 10,409 5,362 15,771 66,836 4,407 12% 3 
TB/Malaria/OID 17,176 0 17,176 172,114 0 172,114 14,106 0 14,106 203,397 7,780 21% 5 
Ghana              
Access to Care 4,585 1,012 5,597 5,436 16,693 22,128 4,669 10,484 15,153 42,879 - - 8 
Build/Improve Facilities 1,187 0 1,187 1,817 0 1,817 13,857 0 13,857 16,861 - - 5 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 1,911 27% 6 
Clean Water 35,991 0 35,991 103,192 0 103,192 89,345 0 89,345 228,527 329 5% 2 
HIV/AIDS 37,726 250 37,976 67,049 22,102 89,151 19,211 1,940 21,151 148,278 955 13% 1 
Hunger and Malnutrition 19,156 0 19,156 23,077 0 23,077 20,065 0 20,065 62,298 152 2% 3 
Immunizations 2,027 0 2,027 0 0 0 528 0 528 2,555 86 1% 9 
Prenatal Care 1,379 0 1,379 3,586 0 3,586 5,549 0 5,549 10,514 863 12% 4 
TB/Malaria/OID 41,558 0 41,558 28,435 0 28,435 89,088 0 89,088 159,080 1,858 26% 7 
Kenya              
Access to Care 8,391 1,369 9,761 30,606 490 31,096 11,776 4,239 16,015 56,872 - - 3 
Build/Improve Facilities 1,645 0 1,645 18,920 0 18,920 12,814 0 12,814 33,379 - - 5 
Chronic Disease 0 197 197 0 0 0 0 10 10 207 2,720 20% 9 
Clean Water 45,132 0 45,132 92,071 9,502 101,574 300,269 0 300,269 446,974 818 6% 7 
HIV/AIDS 148,210 1,944 150,154 279,854 974 280,828 438,713 35,344 474,056 905,038 4,159 31% 1 
Hunger and Malnutrition 17,847 19,532 37,379 37,759 0 37,759 25,389 0 25,389 100,526 230 2% 2 
Immunizations 2,036 0 2,036 1,017 0 1,017 34 0 34 3,086 181 1% 8 
Prenatal Care 3,870 1,187 5,056 14,274 1,885 16,159 3,416 663 4,078 25,294 1,037 8% 6 
TB/Malaria/OID 127,418 404 127,822 40,559 375 40,934 46,675 275 46,950 215,706 2,717 20% 4 
Mali              
Access to Care 16,890 0 16,890 42,797 0 42,797 3,002 0 3,002 62,689 - - 8 
Build/Improve Facilities 1,319 0 1,319 820 0 820 1,680 0 1,680 3,819 - - 4 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 1,224 14% 9 
Clean Water 39,198 0 39,198 35,663 0 35,663 25,449 0 25,449 100,310 750 9% 3 
HIV/AIDS 35,997 0 35,997 5,697 0 5,697 40,755 0 40,755 82,449 419 5% 6 
Hunger and Malnutrition 7,493 0 7,493 28,236 0 28,236 24,612 0 24,612 60,341 414 5% 2 
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Immunizations 1,790 0 1,790 352 0 352 1,569 0 1,569 3,711 243 3% 5 
Prenatal Care 2,167 0 2,167 3,841 0 3,841 6,357 0 6,357 12,364 997 12% 1 
TB/Malaria/OID 11,685 0 11,685 916 5,056 5,973 21,297 1,496 22,793 40,451 2,719 31% 7 
Nigeria              
Access to Care 7,078 60 7,138 22,522 238 22,760 2,819 1,999 4,818 34,716 - - 8 
Build/Improve Facilities 2,346 0 2,346 515 0 515 265 0 265 3,126 - - 6 
Chronic Disease 0 0 0 0 0 0 0 50 50 50 12,429 18% 4 
Clean Water 206,537 0 206,537 125,902 0 125,902 8,597 0 8,597 341,036 4,382 6% 2 
HIV/AIDS 83,165 5,300 88,465 182,344 600 182,944 323,608 3,040 326,648 598,057 9,902 15% 1 
Hunger and Malnutrition 2,019 0 2,019 3,752 0 3,752 37,787 19,897 57,684 63,455 1,360 2% 3 
Immunizations 104,061 0 104,061 45,183 0 45,183 72,482 0 72,482 221,727 6,321 9% 9 
Prenatal Care 11,889 3,950 15,839 1,380 8,755 10,135 9,914 4,880 14,794 40,768 5,344 8% 5 
TB/Malaria/OID 54,679 0 54,679 83,734 49,773 133,508 114,779 0 114,779 302,966 19,527 29% 7 
Senegal              
Access to Care 19,180 180 19,360 69,372 0 69,372 10,835 0 10,835 99,567 - - 3 
Build/Improve Facilities 1,845 0 1,845 5,693 0 5,693 1,118 0 1,118 8,656 - - 4 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 875 23% 7 
Clean Water 63,827 0 63,827 53,547 0 53,547 67,018 0 67,018 184,391 248 7% 6 
HIV/AIDS 7,467 32 7,499 14,515 0 14,515 23,666 750 24,416 46,431 158 4% 5 
Hunger and Malnutrition 4,733 0 4,733 14,076 0 14,076 10,818 0 10,818 29,628 90 2% 1 
Immunizations 615 0 615 135 0 135 193 0 193 943 121 3% 8 
Prenatal Care 1,859 560 2,419 2,004 0 2,004 4,347 0 4,347 8,770 478 13% 2 
TB/Malaria/OID 21,596 3,212 24,808 1,846 0 1,846 21,608 3,965 25,573 52,226 1,292 34% 9 
South Africa              
Access to Care 19,396 55 19,451 71,160 531 71,691 4,811 3,530 8,341 99,483 - - 3 
Build/Improve Facilities 9,865 0 9,865 930 0 930 141 0 141 10,936 - - 4 
Chronic Disease 0 18 18 0 0 0 0 0 0 18 5,161 25% 8 
Clean Water 16,566 0 16,566 58,138 0 58,138 152,715 0 152,715 227,420 479 2% 5 
HIV/AIDS 160,303 2,678 162,981 239,968 1,720 241,688 488,717 2,473 491,189 895,859 10,601 52% 1 
Hunger and Malnutrition 8,707 283 8,990 25 607 631 1,254 0 1,254 10,875 443 2% 2 
Immunizations 0 0 0 0 0 0 0 0 0 0 146 1% 9 
Prenatal Care 1,103 2,439 3,542 750 814 1,564 1,824 1,770 3,594 8,700 585 3% 6 
TB/Malaria/OID 956 0 956 549 0 549 4,766 0 4,766 6,271 1,221 6% 7 
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Tanzania              
Access to Care 49,374 72 49,446 29,861 3,325 33,186 38,227 240 38,467 121,099 - - 6 
Build/Improve Facilities 6,062 0 6,062 7,757 0 7,757 3,317 0 3,317 17,137 - - 4 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 3,154 16% 9 
Clean Water 83,689 0 83,689 116,272 0 116,272 354,571 0 354,571 554,533 1,059 5% 7 
HIV/AIDS 235,838 300 236,138 147,257 475 147,732 264,303 58 264,361 648,232 5,306 26% 1 
Hunger and Malnutrition 3,294 0 3,294 2,215 0 2,215 19,697 0 19,697 25,206 663 3% 5 
Immunizations 909 0 909 389 0 389 488 0 488 1,786 159 1% 8 
Prenatal Care 3,937 200 4,137 61,975 200 62,175 4,766 155 4,921 71,234 1,933 10% 3 
TB/Malaria/OID 56,381 0 56,381 23,045 4,158 27,203 60,672 3,763 64,435 148,019 5,423 27% 2 
Uganda              
Access to Care 23,848 800 24,648 6,096 250 6,346 7,958 586 8,543 39,538 - - 3 
Build/Improve Facilities 37,801 0 37,801 9,357 0 9,357 2,963 0 2,963 50,122 - - 2 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 2,097 16% 9 
Clean Water 45,490 0 45,490 77,690 0 77,690 65,374 0 65,374 188,554 989 7% 7 
HIV/AIDS 127,992 733 128,725 187,908 4,221 192,128 228,071 110 228,181 549,035 2,820 21% 1 
Hunger and Malnutrition 40,895 0 40,895 29,632 0 29,632 41,540 839 42,379 112,906 397 3% 5 
Immunizations 0 0 0 1,250 0 1,250 570 0 570 1,820 739 6% 8 
Prenatal Care 2,544 0 2,544 2,780 198 2,978 5,840 500 6,340 11,862 1,029 8% 4 
TB/Malaria/OID 78,675 459 79,134 3,385 0 3,385 27,563 0 27,563 110,081 3,609 27% 6 
Notes:  Official Development Assistance (ODA) and Private Foundation are analyzed in US 2006 dollars from aid committed in 2006.  ODA data was obtained from the Creditor 
Reporting System (2008) through Source OECD for the year 2006 at a country level (n=27).  Total Donor Aid is the sum of ODA and Private Foundation Giving for the designated 
categories.  Disability-adjusted life-years (DALYs) were obtained from the WHO Global Burden of Disease Estimates (2002).  Percent Disease Burden was calculated as a percentage 
of total DALYs; percentage totals will not add to 100% due to the exclusion of DALYs due to injuries.  Perceived Priorities represent the perceived priority of people surveyed within 
each country, are ranked (1-9, 1 the highest priority), and were obtained from the Kaiser/Pew Global Health Survey (2007). Attributable DALYs were not assigned to Access to Care or 






































The Bill and Melinda Gates Foundation 895,011,143 145 1,536,990,217 136 1,619,838,672 212 
The Ford Foundation 23,910,827 125 29,780,425 136 35,105,892 138 
Rockefeller Foundation 22,389,260 75 15,921,769 34 14,393,835 55 
The David and Lucille Packard Foundation 17,937,038 34 22,535,408 52 26,370,722 57 
The William and Flora Hewlett Foundation 12,624,000 38 20,342,417 34 18,434,500 35 
Top Five Total 971,872,268 417 1,625,570,236 392 1,714,143,621 497 
Percent Total* 95% 70% 92% 38% 89% 44% 
       
Total Giving Top 50 Foundations 1,019,535,087 594 1,767,606,650 1043 1,928,962,978 1126 
Source: See text       
* 2005 Data is only Top 10 
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India 1,057,392 44,572 1,101,964 2,181,906 28,180 2,210,086 2,782,211 16,602 2,798,813 6,110,863 
China 1,278,361 4,871 1,283,232 1,113,198 2,546 1,115,745 1,179,993 22,473 1,202,466 3,601,443 
Bangladesh 718,248 98 718,346 581,656 40,468 622,124 501,240 5,750 506,990 1,847,460 
Indonesia 494,600 2,236 496,836 472,133 2,796 474,930 219,012 2,080 221,092 1,192,858 
Malaysia 746,079 670 746,749 365 852 1,217 1,935 811 2,745 750,711 
Pakistan 173,570 1,300 174,870 355,287 1,150 356,437 188,690 21,533 210,223 741,531 
Latin America           
Argentina 37,717 0 37,717 343,316 306 343,622 399,635 50 399,685 781,024 
Peru 43,312 0 43,312 119,997 599 120,596 261,547 2,005 263,552 427,460 
Brazil 92,075 1,645 93,719 223,061 4,395 227,456 64,406 3,416 67,822 388,997 
Bolivia 81,472 0 81,472 159,400 0 159,400 115,085 0 115,085 355,957 
Mexico 265,267 1,288 266,554 67,336 6,420 73,756 13,002 1,864 14,866 355,177 
Chile 27,147 0 27,147 671 14,517 15,188 141,525 425 141,950 184,285 
Venezuela 16,341 0 16,341 1,428 0 1,428 2,487 0 2,487 20,256 
Middle East           
Morocco 218,679 0 218,679 353,367 0 353,367 272,946 170 273,116 845,161 
Turkey 333,197 0 333,197 47,242 575 47,817 144,001 600 144,601 525,614 
Egypt 133,576 1,087 134,663 69,079 1,518 70,597 200,420 346 200,766 406,026 
Jordan 149,740 0 149,740 107,880 0 107,880 71,415 0 71,415 329,035 
Lebanon 99,291 0 99,291 41,870 0 41,870 36,399 0 36,399 177,560 
Sub-Saharan Africa           
Ethiopia 415,032 3,306 418,337 740,187 21,061 761,248 982,439 20,651 1,003,089 2,182,675 
Kenya 354,548 24,633 379,181 515,059 13,227 528,286 839,085 40,530 879,615 1,787,081 
Nigeria 471,775 9,310 481,084 465,333 59,366 524,699 570,251 29,866 600,117 1,605,900 
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Tanzania 439,484 572 440,056 388,773 8,158 396,931 746,043 4,216 750,259 1,587,246 
South Africa 216,897 5,472 222,369 371,520 3,672 375,191 654,228 7,773 662,000 1,259,560 
Uganda 357,246 1,992 359,238 318,097 4,669 322,766 379,879 2,034 381,914 1,063,918 
Ghana 143,610 1,262 144,872 232,591 38,795 271,386 242,311 12,424 254,735 670,993 
Senegal 121,121 3,984 125,105 161,188 0 161,188 139,605 4,715 144,319 430,613 
Mali 116,539 0 116,539 118,323 5,056 123,379 124,721 1,496 126,217 366,134 
Notes:  Official Development Assistance (ODA) and Private Foundation are analyzed in US 2005/6/7 dollars from aid committed in 2005/6/7.  ODA data was 
obtained from the Creditor Reporting System (2008) through Source OECD for the years 2005/6/7 at a country level (n=27).     Total Donor Aid is the sum of 
ODA and Private Foundation Giving for the designated categories.  Disability-adjusted life-years (DALYs) were obtained from the WHO Global Burden of 
Disease Estimates (2002).  Percent Disease Burden was calculated as a percentage of total DALYs; percentage totals will not add to 100% due to the exclusion 
of DALYs due to injuries.  Perceived Priorities represent the perceived priority of people surveyed within each country, are ranked (1-9, 1 the highest priority), 
and were obtained from the Kaiser/Pew Global Health Survey (2007). Attriubtable DALYs were not assigned to Access to Care or Build/Improve Facilities. 







Table 3: Comparing the correlation of official development assistance and private foundation giving to disease burden 
and perceived priorities for 2005/6/7 aid 













Assistance (commitments)         
2005 0.015  -0.194 ** -0.198 ** -0.14 * 
2006 0.126  -0.202 ** -0.195 ** -0.114  
2007 0.088  -0.21 ** -0.213 ** -0.189 ** 
Private Foundation Grants         
2005 0.059  -0.144 * -0.146 * -0.063  
2006 0.067  -0.12  -0.122  -0.026  
2007 0.02   -0.063   -0.059   -0.073   
Notes: The correlation technique for disability-adjusted life years was standard Pearson's correlation; technique for 
perceived priorities (an ordinal rank) was Spearman's rho. Since the application of Spearman’s rho to denote 
correlation between one ordinal and one interval-ratio set of data may seem problematic, we also converted aid figures 
into ordinal variables by forming nine categories for ODA amounts and five for private grants. In addition, we report 
Pearson's r for completeness. Each observation for disability-adjusted life-years represents the attributable disease 
burden to Clean Water, Chronic Disease, Immunizations, HIV/AIDS and STIs, Malnutrition, Reproductive Health, and 
TB/Malaria/Other Infectious Disease and the committed ODA and US private giving in 2005-07.  Each observation for 
perceived priorities  represents the rank in perceived priority (1-9, 1 the highest) for Access to Care, Build/Improve 
Facilities, Clean Water, Chronic Disease, Immunizations, HIV/AIDS and STIs, Malnutrition, Reproductive Health, and 
TB/Malaria/Other Infectious Disease and the committed ODA and US private giving in 2006 at country level (n=27).  
Official Development Assistance (ODA) and Private Foundation are analyzed in US 2005-07 dollars from aid 
committed in 2005-07.  ODA data was obtained from the Creditor Reporting System (2008) through Source OECD for 
the years 2005-07 at a country level (n=27).  Disability-adjusted life-years were obtained from the WHO Global 
Burden of Disease Estimates (2002).  Perceived Priorities were obtained from the Kaiser/Pew Global Health Survey 
















































































           
  
Clean Water 2,760,521 0 2,760,521 2,266,470 0 2,266,470 2,227,549 0 2,227,549 7,254,539 27,803 4% 4 
Prenatal Care 145,321 11,702 157,023 955,128 35,880 991,007 612,408 11,873 624,281 1,772,311 65,887 10% 3 
HIV/AIDS 379,548 16,191 395,740 222,462 8,106 230,568 1,018,270 29,746 1,048,016 1,674,324 16,574 3% 1 
Access to Care 309,758 24,996 334,754 466,560 16,016 482,576 328,721 3,133 331,853 1,149,184 - - 8 
Hunger and Malnutrition 464,486 300 464,786 173,721 14,967 188,688 239,431 9,701 249,132 902,606 14,865 2% 5 
TB/Malaria/OID 256,502 120 256,622 297,381 0 297,381 193,903 14,406 208,308 762,312 73,651 12% 9 
Build/Improve Facilities 98,854 145 98,999 240,316 0 240,316 48,457 0 48,457 387,772 - - 2 
Immunizations 46,975 0 46,975 73,178 0 73,178 187,705 0 187,705 307,858 17,178 3% 7 
Chronic Disease 0 0 0 0 535 535 0 120 120 655 315,922 50% 6 
Latin America              
Clean Water 379,238 0 379,238 389,885 0 389,885 811,026 0 811,026 1,580,149 1,442 2% 4 
Access to Care 71,892 441 72,333 364,781 1,206 365,987 20,925 200 21,125 459,445 - - 3 
Hunger and Malnutrition 27,830 0 27,830 76,165 5,800 81,965 35,801 150 35,951 145,746 981 1% 1 
HIV/AIDS 50,082 550 50,632 29,596 335 29,931 46,063 2,740 48,804 129,366 1,339 2% 7 
Build/Improve Facilities 21,091 25 21,116 10,334 0 10,334 54,661 25 54,686 86,136 - - 2 
TB/Malaria/OID 4,356 0 4,356 39,910 599 40,509 12,781 1,695 14,476 59,342 3,783 5% 9 
Prenatal Care 6,412 1,916 8,328 4,538 18,140 22,678 16,417 2,949 19,366 50,372 6,269 9% 5 
Immunizations 2,430 0 2,430 0 156 156 14 0 14 2,600 172 0% 6 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 46,326 64% 8 
Middle East              
Clean Water 870,600 0 870,600 509,932 168 510,100 587,895 0 587,895 1,968,595 970 3% 5 
Access to Care 16,133 150 16,283 22,456 0 22,456 52,313 0 52,313 91,052 - - 3 
TB/Malaria/OID 10,174 0 10,174 48,381 0 48,381 22,428 0 22,428 80,983 2,559 8% 9 
Prenatal Care 5,988 605 6,593 6,283 1,625 7,908 28,482 626 29,108 43,609 2,811 9% 6 
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Build/Improve Facilities 7,211 0 7,211 14,850 0 14,850 11,095 0 11,095 33,156 - - 2 
HIV/AIDS 10,859 332 11,191 1,355 300 1,655 19,247 490 19,737 32,583 212 1% 7 
Hunger and Malnutrition 2,929 0 2,929 14,604 0 14,604 1,711 0 1,711 19,244 804 3% 1 
Immunizations 588 0 588 1,577 0 1,577 2,002 0 2,002 4,167 383 1% 8 
Chronic Disease 0 0 0 0 0 0 0 0 0 0 20,511 64% 4 
Sub-Saharan Africa              
Immunizations 2,878,989 0 2,878,989 2,318,706 0 2,318,706 2,331,423 0 2,331,423 7,529,117 37,998 5% 9 
HIV/AIDS 952,388 11,237 963,625 1,302,363 45,306 1,347,669 2,426,739 43,954 2,470,693 4,781,988 38,849 20% 1 
Clean Water 555,623 0 555,623 839,157 9,502 848,659 1,250,045 0 1,250,045 2,654,327 11,153 6% 5 
TB/Malaria/OID 410,124 4,075 414,199 354,583 59,362 413,945 400,554 9,499 410,052 1,238,197 46,146 24% 7 
Hunger and Malnutrition 315,283 19,815 335,098 239,340 607 239,947 262,951 20,735 283,686 858,731 5,136 3% 2 
Access to Care 188,069 3,593 191,662 343,854 22,773 366,627 141,584 36,126 177,710 735,999 - - 6 
Prenatal Care 32,772 11,596 44,368 129,770 16,452 146,221 52,421 13,330 65,751 256,340 16,674 9% 3 
Build/Improve Facilities 63,525 0 63,525 49,768 0 49,768 40,393 0 40,393 153,686 - - 4 
Chronic Disease 0 214 214 0 0 0 0 60 60 274 36,909 19% 8 
Notes:  Official Development Assistance (ODA) and Private Foundation are analyzed in US 2006 dollars from aid committed in 2006.  ODA data was obtained from the Creditor Reporting System 
(2008) through Source OECD for the year 2006 at a regional level.  Total Donor Aid is the sum of ODA and Private Foundation Giving for the designated categories.  Disability-adjusted life-years 
(DALYs) were obtained from the WHO Global Burden of Disease Estimates (2002).  Percent Disease Burden was calculated as a percentage of total DALYs; percentage totals will not add to 100% due 
to the exclusion of DALYs due to injuries.  Perceived Priorities represent the perceived priority of people surveyed within each country, are ranked (1-9, 1 the highest priority), and were obtained from 
the Kaiser/Pew Global Health Survey (2007).  Attributable DALYs were not assigned to Access to Care or Build/Improve Facilities. Eastern Europe, although included in the Kaiser/Pew Global Health 





Table 5: Index comparing aid allocations per capita disease burden  
Region/Country 
Per Capita Disease 


















Asia     
Pakistan 0.30 80,214 2,399,941 2,480,155 
India 0.29 312,697 21,072,588 21,385,285 
Bangladesh 0.26 180,153 7,005,819 7,185,972 
Indonesia 0.21 33,295 5,550,546 5,583,842 
China 0.15 194,365 23,224,577 23,418,942 
Malaysia 0.15 15,945 5,116,888 5,132,834 
Latin America     
Bolivia 0.27 0 1,316,327 1,316,327 
Brazil 0.21 45,630 1,831,690 1,877,320 
Peru 0.19 13,527 2,206,758 2,220,285 
Argentina 0.17 2,147 4,711,418 4,713,565 
Venezuela 0.16 0 124,328 124,328 
Mexico 0.15 63,427 2,290,278 2,353,705 
Chile 0.14 106,626 1,208,473 1,315,099 
Middle East     
Egypt 0.19 15,197 2,075,615 2,090,812 
Lebanon 0.18 0 978,437 978,437 
Morocco 0.17 983 4,888,448 4,889,431 
Turkey 0.16 7,216 3,220,820 3,228,036 
Jordan 0.16 0 2,079,964 2,079,964 
Sub-Saharan Africa    
Mali 0.68 9,571 525,268 534,839 
Nigeria 0.56 174,888 2,675,215 2,850,103 
South Africa 0.56 30,327 2,227,754 2,258,081 
Uganda 0.53 16,275 1,974,970 1,991,245 
Ethiopia 0.53 85,551 4,062,437 4,147,988 
Tanzania 0.46 28,183 3,427,179 3,455,363 
Kenya 0.42 185,926 4,052,694 4,238,620 
Senegal 0.39 22,505 1,091,611 1,114,116 
Ghana 0.35 151,466 1,785,105 1,936,571 
 
 
